MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer

Despite tremendous efforts from scientists and clinicians worldwide, pancreatic adenocarcinoma (PDAC) remains a deadly disease due to the lack of early diagnostic tools and reliable therapeutic approaches. Consequently, a majority of patients (80%) display an advanced disease that results in a low r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gayral, Marion, Jo, Sébastien, Hanoun, Naima, Vignolle-Vidoni, Alix, Lulka, Hubert, Delpu, Yannick, Meulle, Aline, Dufresne, Marlène, Humeau, Marine, Chalret du Rieu, Maël, Bournet, Barbara, Sèlves, Janick, Guimbaud, Rosine, Carrère, Nicolas, Buscail, Louis, Torrisani, Jérôme, Cordelier, Pierre
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2014
Matèries:
Topic Highlight
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145758/
https://ncbi.nlm.nih.gov/pubmed/25170204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i32.11199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars